Page 12 - Latest Updates on Coronavirus
Why Covishield vaccine case doesn't qualify for medical negligence in India
Given the oversight of different regulatory bodies and that Covishield is produced locally by Serum Institute of India, Indian users may not be able to join the British lawsuit
 "Why Covishield vaccine case doesn't qualify for medical negligence in India")
Pregnancy-related deaths have fallen to pre-Covid levels, new US data shows
The Coronavirus can be particularly dangerous to pregnant women. And, in the worst days of the pandemic, burned out physicians may have added to the risk by ignoring pregnant women's worries
 "Pregnancy-related deaths have fallen to pre-Covid levels, new US data shows")
U-WIN may allow mothers to track and report vaccine side-effects on babies
Similar to the CoWIN portal for covid-19, the government's U-WIN platform registers and tracks routine vaccination and immunisation
 "U-WIN may allow mothers to track and report vaccine side-effects on babies")
PM Modi missing from Covid certificates after Covishield row: Here's why
Ministry of Health and Family Welfare informed that PM Modi's photo was removed from Covid certificates due to the Model Code of Conduct (MCC) in effect for the ongoing Lok Sabha polls
 "PM Modi missing from Covid certificates after Covishield row: Here's why")
AstraZeneca admits Covishield has rare side effect: Is concern warranted?
AstraZeneca's acknowledgment that the vaccine may lead to thrombosis isn't a new revelation, but it underscores the need for transparent communication by the pharma companies, say experts
 "AstraZeneca admits Covishield has rare side effect: Is concern warranted?")
Astrazeneca row: Only 7 in a million at risk of TTS, says ex-ICMR scientist
Former ICMR scientist Raman Gangakhedkar said the risk is highest after the initial dose, eventually decreasing with subsequent doses
 "Astrazeneca row: Only 7 in a million at risk of TTS, says ex-ICMR scientist")
AstraZeneca responds to Covishield vaccine concerns: Here's what they said
Regulatory agencies around the world maintain that the risks from the vaccine outweigh the benefits
 "AstraZeneca responds to Covishield vaccine concerns: Here's what they said")
Chinese scientist who published Covid-19 virus sequence back in his lab
Zhang had been staging a sit-in protest outside his lab since the weekend after he and his team were suddenly notified they had to leave their lab
 "Chinese scientist who published Covid-19 virus sequence back in his lab")
AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, cause TTS
 "AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns")
AstraZeneca vaccine: From its origin to side effects, all you need to know
Manufactured first in 2021, the AstraZeneca vaccine, known in India as Covishield, has been facing scrutiny over the years, with many countries banning it back in 2021 itself
 "AstraZeneca vaccine: From its origin to side effects, all you need to know")
India global services export to reach $800 billion by 2030: Goldman Sachs
Report says services exports could reach around 11% of GDP by 2030, helping increase demand for top-tier discretionary spending
 "India global services export to reach $800 billion by 2030: Goldman Sachs")
AstraZeneca admits its Covishield vaccine may lead to rare side effect
AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause rare side effects, marking an about-turn that may open the door for a multi-million pound legal payout
 "AstraZeneca admits its Covishield vaccine may lead to rare side effect")
Baba Ramdev crossed line with false claims of curing Covid: IMA president
The apex court is hearing IMA's 2022 plea alleging a smear campaign against the Covid vaccination drive and modern systems of medicine
 "Baba Ramdev crossed line with false claims of curing Covid: IMA president")
Channapatna's eroding toy story sees a beacon of hope amid Karnataka polls
Ahead of the general elections in Karnataka, artisans who work at these toy factories are demanding the upcoming govt to create a conducive business environment for them and save their "dying" art
 "Channapatna's eroding toy story sees a beacon of hope amid Karnataka polls")
100 scientists spend two years renaming viruses after Covid mistakes
Airborne viruses will be called "pathogens that transmit through the air" under new terminology the World Health Organization hopes will end a scientific rift that hampered early response to Covid 19
 "100 scientists spend two years renaming viruses after Covid mistakes")
Biden govt announces partnership with 50 nations to stifle future pandemics
The announcement comes as countries have struggled to meet a worldwide accord on responses to future pandemics. Four years after the coronavirus pandemic
 "Biden govt announces partnership with 50 nations to stifle future pandemics")
Compensation for death of Covid-19 warriors is not bounty, says Bombay HC
During the pandemic, the state government introduced a comprehensive personal accident cover of Rs 50 lakh to employees
 "Compensation for death of Covid-19 warriors is not bounty, says Bombay HC")
Oppn made Modi govt provide for free Covid-19 vaccines, says Congress
Congress general secretary Jairam Ramesh said the BJP has been touting free Covid-19 vaccinations as a big achievement
 "Oppn made Modi govt provide for free Covid-19 vaccines, says Congress")
Besides Covid-19, diabetes and renal disease reduce Indian lifespan
Covid-19 was the leading cause of death in India, as per the study. The age-standardised rate of deaths for both males and females was 156.8 per 100,000 population
 "Besides Covid-19, diabetes and renal disease reduce Indian lifespan")
Over 80 million people worked under MGNREGA in FY24, shows data
It is the lowest number of beneficiaries to have accessed employment under the scheme since the Covid-19 pandemic
 "Over 80 million people worked under MGNREGA in FY24, shows data")
